🌎 Iovance Biotherapeutics Downgraded, ARM Downgraded, Sarepta Therapeutics Upgraded and more...

Ratings changes for SoundHound AI, CrowdStrike, Longeveron, Iovance Biotherapeutics, Nuwellis, ARM, Sarepta Therapeutics and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe. VIEW MY PORTFOLIO July 29th, 2024     Silver Expected for Extreme Price Action (ad) Our newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PLUS a little-known loophole that allows investors to move a portion of their savings into silver, tax-free and penalty-free. Just click here now to download our Silver Investing Guide for FREE. Today's Top Stories Pharma Giant's Shares Up After Impressive Q2 Earnings Release Chinese glass maker says it wasn't target of raid at US plant featured in Oscar-winning film Beginner Crash Course In Options Trading (Unstoppable Prosperity) It's Time to Rotate Into These Russell 2000 Stocks Insider Q&A: LinkedIn is bullish on AI. Will that help job seekers? Nearly 100% Accurate Indicator Reveals Top Stocks to Buy Greece announces nationwide restrictions to combat 'goat plague' outbreak The key to this new pathway to wealth is literally a key (Porter & Company) Time to Take a Bite of This Stock's Enticing Value S&P 500 Trendlines to Watch Ahead of Big-Time Earnings 4 Reasons to Buy This AI Leader After the Stock Split Unintended consequences: How NIL in college sports has raised questions about nonprofits Quick Links MarketBeat All Access My MarketBeat Account Settings Mobile App Analyst Ratings The tried and true way to get paid time and time again (ad) There's a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You'll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you'll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again. Click here and I'll show you how to build the ultimate dividend portfolio. Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. Analysts' Upgrades Akamai Technologies (NASDAQ:AKAM) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $128.00 price target on the stock. This represents a 30.7% upside from the current price of $97.96. BAE Systems (OTCMKTS:BAESY) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.The current price is $65.30. Booz Allen Hamilton (NYSE:BAH) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $165.00 price target on the stock, down previously from $168.00. This represents a 16.0% upside from the current price of $142.20. Bally's (NYSE:BALY) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $18.25 price target on the stock, up previously from $11.00. This represents a 7.1% upside from the current price of $17.04. Brunswick (NYSE:BC) was upgraded by analysts at Northcoast Research from a "neutral" rating to a "buy" rating. They now have a $100.00 price target on the stock. This represents a 20.1% upside from the current price of $83.26. Carrier Global (NYSE:CARR) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $72.00 price target on the stock, up previously from $55.00. This represents a 8.1% upside from the current price of $66.62. ENI (NYSE:E) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating.The current price is $31.47. Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating.The current price is $63.80. 3M (NYSE:MMM) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock, up previously from $110.00. This represents a 19.4% upside from the current price of $125.58. Northrop Grumman (NYSE:NOC) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $575.00 price target on the stock, up previously from $474.00. This represents a 20.3% upside from the current price of $478.11. Olin (NYSE:OLN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $55.00 price target on the stock. This represents a 22.3% upside from the current price of $44.97. The Shyft Group (NASDAQ:SHYF) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $18.00 price target on the stock, up previously from $12.00. This represents a 17.8% upside from the current price of $15.28. Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $182.00 price target on the stock. This represents a 23.0% upside from the current price of $148.01. View today's most recent analysts' upgrades at MarketBeat.com Biden Deploys Phase 1 Fednow Digital Currency (ad) Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold. Click here to receive your complimentary Wealth Management Guide >> Analysts' Downgrades Federal Agricultural Mortgage (NYSE:AGM) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $215.00 price target on the stock, up previously from $212.00. This represents a 2.8% upside from the current price of $209.22. Amedisys (NASDAQ:AMED) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $101.00 price target on the stock. This represents a 3.0% upside from the current price of $98.05. Alexandria Real Estate Equities (NYSE:ARE) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $126.00 price target on the stock, down previously from $151.00. This represents a 8.0% upside from the current price of $116.69. ARM (NASDAQ:ARM) was downgraded by analysts at HSBC Holdings plc from a "hold" rating to a "reduce" rating. Bristol-Myers Squibb (NYSE:BMY) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $41.00 price target on the stock. This represents a 19.1% downside from the current price of $50.67. Hugo Boss (OTCMKTS:BOSSY) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $7.62. Capital City Bank Group (NASDAQ:CCBG) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $34.00 price target on the stock, up previously from $30.00. This represents a 2.3% downside from the current price of $34.80. Carlyle Secured Lending (NASDAQ:CGBD) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $17.00 price target on the stock. This represents a 5.7% downside from the current price of $18.03. Charter Communications (NASDAQ:CHTR) was downgraded by analysts at Raymond James from a "market perform" rating to an "underperform" rating.The current price is $372.79. Evotec (NASDAQ:EVO) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $6.00 price target on the stock, down previously from $15.00. This represents a 27.9% upside from the current price of $4.69. First Commonwealth Financial (NYSE:FCF) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating. They now have a $19.00 price target on the stock, up previously from $16.00. This represents a 4.9% upside from the current price of $18.12. First Hawaiian (NASDAQ:FHB) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $24.00 price target on the stock. This represents a 4.8% downside from the current price of $25.21. Fortinet (NASDAQ:FTNT) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $57.56. Iovance Biotherapeutics (NASDAQ:IOVA) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $10.00 price target on the stock, down previously from $19.00. This represents a 12.2% upside from the current price of $8.91. Seacoast Banking Co. of Florida (NASDAQ:SBCF) was downgraded by analysts at Hovde Group from an "outperform" rating to a "market perform" rating. They now have a $31.00 price target on the stock, up previously from $29.00. This represents a 10.7% upside from the current price of $28.01. Charles Schwab (NYSE:SCHW) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $64.00 price target on the stock, down previously from $80.00. This represents a 2.3% downside from the current price of $65.50. SLR Investment (NASDAQ:SLRC) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $15.00 price target on the stock, down previously from $15.50. This represents a 4.8% downside from the current price of $15.76. SPS Commerce (NASDAQ:SPSC) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating.The current price is $206.30. 1st Source (NASDAQ:SRCE) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $67.50 price target on the stock, up previously from $60.00. This represents a 6.4% upside from the current price of $63.42. Stellantis (NYSE:STLA) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.The current price is $16.75. View today's most recent analysts' downgrades at MarketBeat.com First a 1,129% win in 2 days... .Now this??? (ad) Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans... Click here to see how >>> Analysts' New Coverage ABIVAX Société Anonyme (NASDAQ:ABVX) is now covered by analysts at Laidlaw. They set a "buy" rating and a $48.00 price target on the stock. This represents a 302.3% upside from the current price of $11.93. Aclarion (NASDAQ:ACON) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $1.60 price target on the stock. This represents a 382.8% upside from the current price of $0.33. Air Lease (NYSE:AL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $58.00 price target on the stock. This represents a 16.2% upside from the current price of $49.91. Astria Therapeutics (NASDAQ:ATXS) is now covered by analysts at TD Cowen. They set a "buy" rating and a $35.00 price target on the stock. This represents a 196.6% upside from the current price of $11.80. Cibus (NASDAQ:CBUS) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $25.00 price target on the stock. This represents a 138.5% upside from the current price of $10.48. GigaCloud Technology (NASDAQ:GCT) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $50.00 price target on the stock. This represents a 69.4% upside from the current price of $29.52. Lithium Americas (NYSE:LAC) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $3.90 price target on the stock. This represents a 43.9% upside from the current price of $2.71. Modine Manufacturing (NYSE:MOD) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $103.01. Nuwellis (NASDAQ:NUWE) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $17.00 price target on the stock. This represents a 432.9% upside from the current price of $3.19. Shake Shack (NYSE:SHAK) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $95.00 price target on the stock. This represents a 13.8% upside from the current price of $83.51. Simulations Plus (NASDAQ:SLP) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $47.00 price target on the stock. This represents a 16.7% upside from the current price of $40.29. View today's most recent analysts' new coverage at MarketBeat.com Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Unusual Options Volume Unusual Trading Volume Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Urgent alert: open this for a huge profit potential